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Abstract. Early diagnosis and treatment is the principal strategy to control visceral leishmaniasis (VL), or kala-azar in
EastAfrica. AsVLstrikes remote rural, sparsely populated areas, kala-azar caremight not beaccessedoptimally or timely.
Weconducted aqualitative study to explore accessbarriers in a longstanding kala-azar endemic area in southernGadarif,
Sudan. Former kala-azar patients or caretakers, community leaders, andhealth-care providerswere purposively sampled
and thematic data analysis was used. Our study participants revealed the multitude of difﬁculties faced when seeking
care. The disease is well known in the area, yetmisconceptions about causes and transmission persist. The care-seeking
itineraries were not always straightforward: “shopping around” for treatments are common, partly linked to difﬁculties in
diagnosing kala-azar. Kala-azar is perceived to be “hiding,” requiring multiple tests and other diseases must be treated
ﬁrst. Negative perceptions on quality of care in the public hospitals prevail, with the unavailability of drugs or staff as the
main concern. Delay to seek care remains predominantly linked to economic constraint: albeit treatment is for free,
patients have to pay out of pocket for everything else, pushing families further into poverty. Despite increased efforts to
tackle the disease over the years, access to quality kala-azar care in this rural Sudanese context remains problematic. The
barriers explored in this study are a compelling reminder of the need to boost efforts to address these barriers.
INTRODUCTION
In eastern Africa, inadequate access to early diagnosis and
treatment is a critical barrier to the control of visceral leish-
maniasis (VL). Despite a decline in global estimates, the region
continues to report high and gradually increasing number of
cases.1,2 Visceral leishmaniasis, also known as kala-azar, is
almost always fatal without timely treatment.3 Delays in di-
agnosis and treatment not only increase the risk of morbidity
and mortality, but also the risk of transmission of infection to
others.4 Visceral leishmaniasis control has been hampered by
poorly functioning health services, but, on the other hand,
increased supply does not always guarantee optimal uptake
of services nor impact on the epidemiological trend.5,6 Health-
seeking behavior toward kala-azar in these sparsely popu-
lated rural and underserved areas is complex.
Visceral leishmaniasis is caused by intracellular protozoa
from the Leishmania species and transmitted by bites of a
Phlebotomine sandﬂy. Its symptoms—prolonged fever, loss
of appetite, and spleen enlargement—may mimic other dis-
eases such as malaria, typhoid fever, tuberculosis, or bru-
cellosis. Malnutrition, poverty, and immunodeﬁciency are
known risk factors for developing kala-azar disease,7,8 and
civil unrest, migration, and severe food shortages have led to
large VL epidemics in the past.9,10 The disease dispropor-
tionately affects the poor and marginalized, and, in a vicious
circle, pushes the affected families into further destitution.11,12
Sudan bears one of the highest VL burdens in the world
reporting 2,000–7,000 cases per year.13 Visceral leishmania-
sis is thought to be primarily anthroponotic here.14 Vector
control strategies for VL include insecticide spraying, use of
insecticide-treatedmaterials, andenvironmentalmanagement.15
Unfortunately not much evidence exist about their effective-
ness in eastern Africa and they are not widely used. In the
absence of vaccines and effective vector control strategies,
case detection and treatment remains the principal VL control
approach. The national VL control program is in place for more
than 10 years, providing diagnosis and treatment at public
hospitals as a main strategy.16,17 Diagnosis relies on an anti-
body detection test, the direct agglutination test, or rK39-
based rapid diagnostic test (RDT), or on parasitological
examination.18 Since 2011 the ﬁrst-line treatment is 17-day
injections of antimonial and paromomycin,19,20 requiring
hospitalization for part or the entire course. Late presentations
to the hospitals are common, especially in a predominantly
rural area such as Gadarif.21
Gadarif state of eastern Sudan contributes to 80% of the
number of VL cases reported in the country.22 The southern
part of Gadarif is a highly endemic zone with an incidence rate
of 75 casesper 10,000persons per year in a village-level study
in 2012.23 Not all VL patients present themselves to the hos-
pital, although the underreporting seems to improve in recent
years.24,25 Over the past 30 years, several nonstate actors
provided support to the Ministry of Health (MoH) to tackle VL,
yet the number of cases remains high and access to VL care
remains a critical issue in this region. In these large expanses
of hard-to-reach, isolated areas there are limited number of
hospitals where VL can be treated. During the rainy season
(May–October), many roads are impassable, and subsistence
farmers and laborers will prioritize the agricultural calendar
and postpone dealing with any health matters during these
months.26 Although the governmental hospitals offer VL
treatment free of charge to patients, other costs such as
transport, registration, admission, drugs for concomitant
diseases, and laboratory tests are not for free.27 Drug short-
ages have been observed in the MoH services, further re-
ducing access to treatment of many. Cultural barriers exist
as well. Nomadic groups lack awareness of the disease.
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Restrictions on women’s decision-making power and use of
traditional remedies have also been identiﬁed as access bar-
riers in a study conducted 13 years ago.28 All these barriers
taken together may result in a long delay between the onset of
symptoms and treatment, complicating VL case manage-
ment, and the chance of treatment success. Treatment de-
faulters and losses to follow up are common, and the reasons
behind are poorly understood.26 Most interventions in the last
decade, however, have been focusing on the supply side of
the health service by opening more VL treatment centers, and
supplying themwithRDTsandmedicines. The reasonsbehind
the continued stagnation/increase in the number of reported
VL cases, even across villages with similar conditions, are still
largely unknown.29,30 The perspectives of the people them-
selves, as end users, are rarely investigated.
This qualitative study aimed to explore the perceptions and
attitudes of the community to understand the barriers in
accessing kala-azar care in this setting. A better under-
standing of the social context of kala-azar in an endemic
area such as Gadarif would generate insights on practical
ways to enhance access to care and adjust future control
activities.
METHODS
Conceptual framework. In this study, we consider “ac-
cess” in terms of whether those who need kala-azar care get
into the care system andwhat factors impede this access.We
initially adopted the three-delays model from Thaddeus and
Maine (delay in thedecision to seekcare, delay ingetting to the
facility, and delay in obtaining appropriate care once at the
facility)31 and further incorporate the health behavior model of
Andersen32,33 that focuses on utilization of health services.
Thismodel aims to explain use of health services as a function
of a set of predisposing factors, enabling/disabling factors,
andneed factors. This frameworkguided the structuringof our
ﬁndings into individual-, population-, and health-system lev-
els barriers that inﬂuence health-seeking behavior toward
kala-azar.
Study setting and population. Gadarif state has a total
population of 1.4 million, spread over 75,000 km2.34 It is eth-
nically very diverse—many Arabic, western Sudanese, West
African, and non-Sudanese tribes settled there during the
agricultural boom in the 1960s.35,36 The vegetation consists of
a typical dry savannah woodland, with Acacia and Balanites
trees, combined with black cotton soil. Agriculture is the main
livelihood, with sorghum, sesame, and millet as major crops.
More than half of the population live in rural areas, and only
60% are literate.37 Most people are subsistence farmers or
engage in small animal husbandry. Socioeconomic inequal-
ities are high, due to the expansion of large mechanized
farming based on underpaid wage labor. High demand for
manual labor attracts seasonal workers (from within Sudan or
bordering Ethiopia) during the rainy season.
The study was conducted in three most VL–endemic lo-
calities in southern Gadarif – two located along the Atbarah
and Rahad river basins (Qureisha and al Rahad, respectively)
andonedirectly borderingEthiopia (EastGalabat) (Figure 1). Al
Rahad locality is served by two hospitals, Um el Kher (sup-
ported byMe´decins Sans Frontie`res [MSF] in 1996–2005) and
Bazoora (also supported by MSF starting in 2017). East Gal-
abat locality, is served by one rural hospital (Basunda) and one
specialized kala-azar center (Doka) supported by the research
agency Drugs for Neglected Disease Initiative). The al Qurei-
sha locality is served by a kala-azar center supported by MSF
since 2009 (Tabarak Allah).
Historically, MoH was in charge of and providing kala-azar
care in Gadarif. When a VL outbreak unfolded in 1995–1996,
efforts to study and tackle the disease increased, which in-
cluded collaborations between the Sudanese and interna-
tional actors. non-governmental organizations (NGO) as MSF
have treated thousands of VL cases in dedicated clinics. More
recently, the KalaCORE consortium is supporting MoH to
improve routine kala-azar services since 2015. In 2017 there
were 10 public hospitals designated to diagnose and treat
kala-azar, including the referral hospital in Gadarif town.
Study design.Weconducted a qualitative study combining
in-depth interviews (IDI) with individual key informants and
focus group discussions (FGD) to add breadth to the data and
triangulate the ﬁndings.38 Data collection took place in March
2017. The ﬁeld research team was composed of equal num-
bers of members with biomedical and social science back-
grounds, four females and four males, and supervised by the
principal investigator (T. S.). We purposively selected three
villages from each locality, one with a high number of cases in
the last year, one with low number, and one with the worst
physical access to any kala-azar treatment centers in terms of
roads. We decided on this choice of villages in two meetings
between the research team and community facilitators from
the localities, using village level kala-azar data from state
MoH. The purposive sampling was chosen to ensure maxi-
mum depth and variation of information, including typical and
deviant cases. Participants for IDIs consisted of three cate-
gories: former kala-azar patients or caretakers (as community
member), community leaders, and health-care provider. Par-
ticipants for FGDs consisted of community members only, as
involving community leaders or health workers in the discus-
sions may introduce bias.
We introduced the study and the aims to local village chiefs,
and community facilitatorswho previously invited participants
for FGDs further approached key informants for a face-to-face
interview. If participants were willing to participate, the re-
search team visited them in their home and obtained a written
consent before conducting the IDIs. Group verbal consent
was taken before FGDs. Health workers in the area were
consulted but to avoid bias as much as possible the IDIs and
FGDs were not conducted in the health centers. Between 7
and 12 people participated in each FGD which lasted 45–60
minutes,whereas the IDI lasted onaveragebetween40and90
minutes.
Focus group discussions were conducted separately for
women and men. The interviewer/moderator was of the same
gender as a participant(s). All interviews and FGDs took place
in the participants’ homes or other private and conﬁdential
areas and were, after permission, recorded on a digital voice
recorder. Semistructured topic guides were used to guide the
IDIs/FGDs, and additional items were included as data col-
lection progressed. Data collection continued until saturation
was reached and no new information emerged. All interviews
were conducted in Arabic, the main local language.
Data management. To ensure quality of data, we put for-
ward the following mechanisms during data collection: 1)
permanent supervision of the study by the principal in-
vestigator (T. S.) and 2) frequent exchange and feedback
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sessions among the study team in the ﬁeld. Before study
implementation, the team completed a 3-day training
workshop, after a pilot test of study tools in one village
nearby Gadarif town. Records from the study were tran-
scribed verbatim,while anArabic language expert and native
speaker (G. K. A.) supervised the data transcribing and
translation process. The subsequent English translation
was carried out by a team from a local English language
institution and cross-checked by two researchers (R. A. B.
and N. A.).
A public health specialist (T. S.) and anthropologist (C. V. K.)
independently analyzed the data using a thematic analysis
approach.39,40 Themes were identiﬁed through careful
reading and re-reading of the data, and if patterns were
recognized, these emerging themes became the categories
for analysis. This analysis method combines a deductive
FIGURE 1. Map of Gadarif state in eastern Sudan and localities where the study is conducted. This ﬁgure appears in color at www.ajtmh.org.
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approach - throughpredeﬁned themes in thequestions guide-
and data-driven inductive approach allowing for themes to
emerge from the data. Three researchers (T. S., C. V. K., G. K.
A.) conducted the reﬁnement and reconciliation of coding
through frequent discussions about deviations and common
themes. All team members were involved in revising the
coding schemes, organizing the codes and corresponding
quotes to identify consistencies and contradictions in the
data and interpretation. NVivo software (version 11; QSR
International, Melbourne, Australia) was used to aid the data
management during analysis.
Ethical statement.We obtained ethical approval from the
National Health Research Ethics ReviewCommittee, Federal
MoH of Sudan and from Institute of Tropical Medicine Ethical
Review Board. Permissions to conduct the study were
obtained from the State MoH, local authorities, and MSF.
Written informed consent was obtained from each study
participant or their parent/guardian for the nonadult partici-
pants, in addition to their assent. Additional oral consent was
obtained for using digital voice recorder. Participation in the
study was voluntary, and any information provided was kept
conﬁdential. Quoted information was anonymized during the
analysis and reporting.
RESULTS
A total of 191 individuals participated (see Table 1).
Kala-azar is well known, yet with varying level
of misconceptions. Kala-azar is a well-known illness and
familiar tomany, as almost all participants knewsomeonewho
suffered from it. The history of VL goes back a long time in
Gadarif. Respondents told that the disease was previously
known under the local name “maraad sayeed,” literally
meaning “disease of the south”—referring to the upstream
river basin areas. Other vernacular synonyms for kala-azar
were “tohaal” (abdominal swelling), “suffair” (jaundice), and
“ghibia” or “jini wardah” (recurring fever). Our respondents
describe the disease as characterized by bouts of fever, ab-
dominal swelling, low appetite, and weakness. People also
linked kala-azar with vomiting, headache, yellow skin, pale
eyes, nose bleeding, dry lips, and anxiety.
Respondents claimed that the name “kala-azar” was only in-
troduced when “outsiders” came to Gadarif to investigate the
“killing disease” outbreak in the 1990s. These outsiders were
doctors and researchers from Khartoum and abroad and they
were the ones who told the villagers about a “sandﬂy” causing
thisdisease.Respondents fromthevillagesalong theRahadand
Atbara riversweremostly able to correctly identify the sandﬂy as
the transmitting agent, and its association with the lalob
(Balanites aegyptica) and taleh (Acacia seyal) trees, cracks of
the soil and the mud huts, and animal dirt. However, some par-
ticipants did not knowwhat causes kala-azar and attributed it to
hunger, contaminated water, mosquitoes, unhygienic houses,
and staying outside the village on the farmland. Some partici-
pantsbelieved that thediseasecouldbepassed fromperson-to-
person in the same house. Drinking water or sharing food with
patients, sleeping in the samebed, and clothes and sweat of the
patients were also evoked by some as ways to get infected.
“Because when you eat or drink some of the food or
drinksmeant for the sickperson, youwill be infected.When
this disease infects a person in a family, it must also infect
two or three other persons” [IDI, Male, Community leader]
Some people said that everyone, rich and poor alike, can get
kala-azar. However they acknowledged the vulnerability of some
groups: children, or the young, in general, were thought to be
more at risk, as they play outside close to the trees where the
sandﬂy livesandhave “weakerblood.”Familymembersandpoor
familieswith food insecurities are also perceived to be at a higher
risk to get kala-azar. Certain areas were thought to be more at
risk: villages along the river and the deep remote settlements far
from the road. A few participants hinted that certain tribes have
“more kala-azar”: the Hausa and Masaleet were mentioned; al-
though for most respondents the geographic location of their
villages matters more. Most respondents linked the abundance
of sandﬂieswith the increasednumber of kala-azar after the rainy
season/autumn, alsoknown as the “sesame season.”Several
mentioned that the general fatigue that people experience
after harvesting, makes it easy to contract kala-azar.
“Yes, hunger causes it, the sandﬂy brings it. The person
who does not eat enough deﬁnitely he will be sick and the
illness will increase. When the ﬂy ﬁnds that your blood is
weak, it (kala-azar) strikes you” [FGD, Female, Kersyba]
Diagnosis delay and multiple trajectories (getting di-
agnosed is not an easy feat). Participants who had kala-azar
in the past or cared for family members with kala-azar claimed
that the search for a deﬁnitive diagnosis is a major challenge.
People ﬁrst try to self-medicate, adopting a “symptomatic”
approachwith distinct healingmethods for each afﬂiction. For
example, they rub oil and herbal paste against fever, cut or
burn skin against the abdominal swelling, drink herbal con-
coctions from various roots for yellow skin, or drink water that
has been blessed by readings fromQur’an (muhaya) as amore
general measure. The association with “bad blood” led to the
practice of bloodletting, “letting the black blood run,” after
which the wound is tied up with tree barks. If these attempts
are unsuccessful, then only people resort to the formal health
TABLE 1
Characteristics of the participants of IDI and FGD
Females Males Total
In-depth
interviews
10 14 24
Age group 14–25 2 0 2
26–35 2 5 7
36–45 4 2 6
46–65 3 6 9
Categories Community
members*
8 4 12
Community
leaders†
1 4 5
Health-care
workers
5 2 7
Focus group
discussions
9 10 19
Locality Rahad 4 5 9
Qureisha 2 2 4
East Galabat 3 3 6
FGD = focus group discussions; IDI = in-depth interviews.
* Community members: former kala-azar patients or caretaker of a patient.
†Community leaders: members of people’s committee, school principals/teachers,
merchants, or religious leaders.
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system—this might be the village health center or clinic,
nearest rural hospital, or pharmacies, depending on circum-
stances and availablemoney. Private clinics are rare except in
Gadarif town.
However, many participants said that the traditional treat-
ment is a thing of the past, from the time when the kala-azar
drug was neither known nor available. These traditional or
religious practices still have their place if the kala-azar test
results are negative. Traditional healing practice seems
ubiquitous, not only in remote villages. It is also enhanced by
the ﬁnancial barriers linked to the formal health system.
“Whenwe do not know, we treat him traditionally. If not
healed, we take him to the doctor to inject him, (but) to
take the injection he needs to be tested ﬁrst. When you go
the doctor, regardless if kala-azar appears or not, the
doctor gives an injection for malaria and inﬂammation. If
this fails, then we need to take him to the doctor for (an-
other) testing.” [IDI, Female, Former kala-azar patient]
“. . . I have seen it for a long time that local medicine
does not cure kala-azar.What is curedby localmedicine is
“Um-Siffair” - jaundice – trees can cure that. However,
kala-azar needs kala-azar medicine. Sometimes, it needs
some localmedicine to comeout andbe found. This is the
case when it does not show at ﬁrst in the laboratory test.”
[IDI, Male, Former patient]
People mostly believed that kala-azar can only be found after
multiple tests. The “easy” type of kala-azar is the one that is
detected immediately, whereas the “difﬁcult” one is the one with
repeated negative test results. Kala-azar is to a large extent
thought to be “hiding” in the body and will only show itself after
evolving frommalaria, inﬂammation, or typhoid. In theexperience
of many, there is a need to be treated for other diseases ﬁrst.
“Wesay it ismalariaﬁrst and then it changes into kala-azar.
Sometimes they say typhoid. Malaria becomes typhoid
and typhoid becomes kala-azar” [FGD, Male, Rymila]
“Kala-azar is a dishonest disease. If there is any other
disease in your body, then kala azar will not appear in the
test until you get rid of all the diseases you have.” [FGD,
Male, Tabarak Allah]
Most participants indicated that if they suspect kala-azar,
they will seek to conﬁrm this through repeated investigations;
especially in a bigger town such as Gadarif, where a private
laboratory, in particular, is known to be a trusted kala-azar
laboratory in the state. The village-level health center and the
clinics only perform RDTs for malaria. Hence many respon-
dents described their experience having to undergo multiple
tests in various places, either referred or by their own volition, in
search of the ﬁnal kala-azar diagnosis. When the results turned
out negative, several respondents attribute it to the lack of ex-
perience of the technician or unavailability of “sophisticated
machines.” Health workers said that the RDTs are not reliable
and that only bymicroscopy the diagnosis can be ascertained.
“We are poor. I have two children who had kala-azar. I
went to Gadarif ﬁve times. All tests and ultrasound exams
did not discover the disease, so they told me to go to
Ahmad Daneel (the private kala-azar lab). When he saw
them, he said it was kala-azar and transferred me to Doka
hospital. When I came, they told me to pay 12 pounds for
tablets, and I paid, but they gave me nothing. Waited for
another day and again nothing. Then I went to Tabarak
Allah center, and they started the tests again,my ﬁrst child
and then his brother was found positive but they re-
covered, and they are well” [FGD, Male, Rymila]
Participants also discussed speciﬁc food items that are
believed to force kala-azar to appear, such as banana,
chicken, and ﬁsh. Some respondents said that this wide-
spread belief was initially promoted by the doctors, although
health-care workers refuted this. According to our respon-
dents, this food would make the symptoms worse and push
the kala-azar to appear.
“Sometimes, when it is too difﬁcult to ﬁnd kala-azar in
laboratory tests, the sick person is told to gohome andeat
bananas.” . . .” [IDI, Male, Former patient]
When kala-azar is ﬁnally diagnosed, this is seen as a
blessingor good luck. People congratulate thepatientwith the
positive test. People widely felt relieved when kala-azar is di-
agnosed, as they assume that now cure is within reach and
further money expense can be avoided.
“Thedemonaccompanying kala-azar is the fact that the
disease does not appear easily. So when you meet the
doctor for diagnosis, you may feel tired and exhausted.
You have nothing at home. Before you do the test, they
say ‘your medicines are this and that’, and ‘we test, you
give the money’ You have no money to pay them. Here
you feel worried and anxious... Afterwards when kala-azar
appears, you say thanks and praise to Allah. This is a
blessing.” [FGD, Male, Bazoora]
The journey to obtain the diagnosis is a huge challenge and
these hurdles are evoked as the most important reason to
delay coming to the hospital. Treating the initial symptoms
with medicines brought from the market is also common and
seen as part of the “diagnostic process.”
“In case someone is sick, he comes here to the hospital
and if no kala azar is found [immediately], he goes away
and buys the medicine from outside. In reality, he may
have kala-azar, yet he buys themedicine from outside and
many patients are lost this way. A person’s health wor-
sens, and they bring him here when it is too late.” [IDI,
Female, Health care worker]
Variable quality of care in different treatment centers.
The irregular availability of the kala-azar medicine at the hos-
pital was a source of concern for many respondents. People
who have to wait for the drug linger several days at the hos-
pital, and in some cases are referred to places with a higher
likelihood to have the drugs. Several respondents experi-
enced this ﬁrsthand, and few mentioned that the medicine
could be bought outside the hospital. Universally known as
“kala-azar injection,” it seems that people can purchase the
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vials in an informal circuit if they know someone from “inside”
this black market.
“By Allah, the reason of death is nothing else than un-
availability of medicine. Sometimes it is tough for people
to ﬁndmedicine when they are sick with kala-azar, so they
die because of lack of treatment. The medicine is not
available all the time, and sometimes youwill ﬁnd a person
took two or three injections then themedicine is ﬁnished.”
[IDI, Male, Healthcare worker, Tabarak Allah]
“If you know the right local person, you tell him that you
need kala azar drug for your son, they tell you ok, we will
give you the drug, and the cost is 500 pounds [US$75]”
[IDI, Male, Caregiver]
Most participants said that the injections are the only cure
for kala-azar and had no doubt about its effectiveness. How-
ever, they also mentioned that the drug is “heavy” and “burns
the blood.” The change in the duration of treatment, from
30 days to the current 17 days was noticed and to some,
generated a concern that kala-azar relapse happens more
often with the new regimen. People also said that there is
some food to be avoided to prevent kala-azar relapse or skin
spots (referring to the post-kala-azar dermal leishmaniasis),
such as Sudanese groundnuts (foul or dakwa) or beans. Par-
ticipants from kala-azar–affected households expressed their
negative feelings toward the health-care system. They men-
tioned the poor facilities (such as inadequate bed capacity),
lack of medical staff, the commercial motives (everything has
its fee), and the variable quality across hospitals. The hospitals
that are supported by NGO stand out because all care is
provided for free and kala-azar patients receive additional
support, thus serve as an incentive for the patients.
“During the period of treatment they used to give pa-
tients soap, ﬂour, and oil for cooking, the sick person gave
multivitamin, milk, madeeda (porridge) so when he gets
out of the hospital, he was ﬁt.” [IDI, Male, Former patient]
“We did two years without a doctor in the normal (not
Kala-azar) ward,whileMSFmanaged theKala-azar center
next to it. Theorganization is very good, but there is agreat
difference: the governmental hospital is very poor in ev-
erything and the government’s doctor is paid a weak
salary.” [FGD, Male, Tabarak Allah]
The perpetual poverty and the taxing journey to
reach care. To deal with a kala-azar episode is costly; this is
acknowledged by all IDIs and FGDs participants without fail.
Although kala-azar drug is ofﬁcially provided free of charge,
there are many other expenses for the kala-azar patients and
their families, which they have to pay out of pocket. These
include hospital entry ticket, different laboratory investiga-
tions, bed, syringes, medicines for other nonkala-azar condi-
tions, and meals for the caretakers. Participants described
their coping mechanisms such as borrowing money, selling
cattle/crops, or asking help from the Islamic charity zakat. The
ﬁnancial losses are felt both in the short- and long-term, and
often stood as the main reason for not taking the sick to the
hospital.
“The ﬁnancial situation is so bad; you ﬁnd the families
(who) are too poor to have food for tomorrow or even the
day, they have no money to see a doctor and buy medi-
cine, so he stays with his disease (kala-azar). They say
thank god if recovered, if not then it is God’s will” [FGD,
Male, Um el Kher]
“It is difﬁcult here to be sickwith nomoney because you
need two pounds (US$0.3) to get to the hospital and 20
pounds (US$3) to see the doctor, who will give you three
tests,malaria, inﬂammation or typhoid. The result may not
show kala-azar, but he has it. Then you start testing again,
and that may cost 60–70 pound$ (US$9–10.5), always
need to get back (to the hospital) with the sick - such case
is normal here, and when your pounds are ﬁnished, there
is nothing to give him but the traditional treatment” [IDI,
Male, Community leader]
The transportation cost to get to the hospital varies with
season. During the rainy season, transport costs increase
signiﬁcantly as the roads are ﬂooded. The participants de-
scribed how the sickwere carried by stretcher, on boats or on
a tractor that may take days or weeks to reach the hospital.
Because of this difﬁculty, many respondents expressed that
people would rather wait until the rainy season is over to seek
kala-azar care, and will wait even longer, if there are agri-
cultural chores. The unstable income during this period, to
some participants, also acts as a deterrent from seeking
timely care.
“Now, in this area for about eight months you [to the
interviewer] can’t reach us here, I am sure. The tractor was
stuck for a day on a stretch where the car can cut in 15
minutes.” [IDI, Female, Caregiver]
“First thing is the road, the distance between Barbar
and Tabarak Allah is ﬁve kilometers, and it takes 6 hours to
reach there with the mud. . .very exhausting. Moreover,
people in the rainy season need to buy seed, so they do
not have the money to take the patient to Tabarak Allah.
From less than 10 pounds (US$1.5) thiswill now cost 300
to 400 pounds (US$45–60), and you have to rent a spe-
cial vehicle.Many areas are completely cut-off during the
rain. Poor people could not take their son to the hospital
even if he was dying in front of them. ” [IDI, Male, Former
patient]
“The problem is that in autumn, people’s ﬁnancial sit-
uations are very difﬁcult. The patient’s family does not
have anything. People collect money for him and write an
application to the “Zakat chamber,” and you do not get
enough money to help you, it is a complicated situation.”
[FGD, male, Rymila]
Gender inequalities further exacerbates kala-azar im-
pact on the family. Kala-azar is broadly perceived as a
dangerousdisease and should be taken seriously. The notion
of danger is linked to its severity and perception that kala-
azar ultimately kills or causes death. Most female partici-
pants were aware that kala-azar or its treatment can cause
abortion.
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“It is the most dangerous disease because it is difﬁcult
to be cured. Other diseases can be cured in the nearest
hospital but kala-azar only in organizations or centers. It
is so expensive, it costs 3000 or 3500 pounds (US
$450–525). We think it is themost dangerous disease as it
causes death” [FGD, Male, Barbar el Fugara]
When a family member is suspected to have kala-azar, al-
though both parents are responsible to decide what to do, the
woman or the mother is in a disadvantaged position. The
women are expected to handle multiple tasks: household
chores, agricultural work, and childcare. Permission from the
husbands or male family member is culturally required, al-
though this is strongly linked to the ﬁnancial solvency as the
husband’s prerogative. However, respondents also said that
women could help raise the money, either by selling crops or
reaching to the collective community resources.
“To get the medicine you have to buy it, so probably
sometimes youwill not havemoney, sometimes the father
also is not around. A sick child may spend 15 days before
going to the hospital, why? The mother tells you that the
fatherwasnotaroundand there isnomoney.Shehas towait
till the fathercomesbeforedoinganything.Somepeoplesell
their sheeporgoat in themarket togetmoney.Somoney isa
major problem, (it) will block everything and that iswhy there
is a delay.” [IDI, Female, caregiver]
Many female participants spoke of the impact of kala-azar
on the family, the emotional toll to deal with anxiety related to
the disease and premature death, and further impoverishment
to the family, even if the patient is not the main breadwinner.
Having to stay in the hospital disrupts their life, as the work in
the ﬁeld has to be abandoned or delegated to other people.
“The family will be troubled despite their poverty they
do what is beyond their abilities. All the family care should
be directed to the patient, kala-azar is most dangerous
disease here and is still a problem.” [IDI, Female,
Caregiver]
Limited efforts to control the disease. Participants from
villages with a high number of kala-azar cases in the past
indicated that the disease has somewhat “decreased” now,
although few mentioned that it might increase again. Most
people perceived a change in the situation, attributed to var-
ious things such as the presence of “organizations,” health
education, and preventive measures, e.g., spraying cam-
paigns, mosquito net distribution, and cutting trees.
“In the past, kala-azarwasmore commonhere, but now
and after the organization came the disease is reduced.
The people come to our area from different regions to get
treatment here. The deaths are also much less. The peo-
ple nowadays use nets, they know how to control the
disease, and there is health education for us. Previously,
there were only grass and bushes which are a good en-
vironment for the ﬂy.” [IDI, Female, Health care worker]
The preventive measures, however, are not entirely per-
ceived as successful. Both the villagers and health-care
workers expressed their weariness, as to the use of mosquito
nets (too hot in summer time), the ineffectiveness of spraying,
and the abundance of trees, even if they are permitted to cut
them.
“We are worried about the cause of the disease and
treatment. However, we keep asking how to ﬁght the
sandﬂy? From our experience to cut down trees and run
after the sand ﬂy to catch it, [everybody laughs] this is a
failure.” [FGD, Male, Tabarak Allah]
When asked about what more could be done to tackle the
disease, many participants expressed that more centers are
needed for the hard-to-reach areas, includingmore laboratory
and more doctors. Although some participants wished that
kala-azar–speciﬁc activities such as spraying, net distribution,
and health education programs (in the mosque or school)
would be improved, others say that economic programs to
tackle poverty would be more critical. Many respondents
spoke of the need for more roads and better transportation in
autumn.
“I would say that the State should help citizens, treat
them & deal with the things that are difﬁcult for them to
handle. “The poor citizen cannot get medicine and
searches for the cost of treatment.” [IDI,Male,Community
leader]
DISCUSSION
This qualitative study explored the barriers to access kala-
azar care in endemic areas in southern Gadarif, Sudan, from
the perspective of the people. Our ﬁndings describe the mul-
titude of difﬁculties people face when seeking kala-azar care,
and illustrate the prevailing hardship in a rural Sudanese
context. The various barriers, as experienced and narrated by
study participants, are depicted in Figure 2. Access to health
care is always amultidimensional phenomenonclosely related
to the health-seeking behavior of the population. However, in
this region the perception of illness and care is predominantly
shaped by poverty and other structural problems in an ex-
tremely resource-constrained setting.
Both the three-delays and health behavior models have
beenused inmanyhealth topics,41–44 yet this is the ﬁrst time to
apply them to the context of kala-azar inSudan.Our studywas
designed to explore what barriers persist from the community
perspective on kala-azar care. The predisposing characteris-
tics at community and health system levels inﬂuence the
“propensity” of individuals to seek care (stage of the decision
as the ﬁrst delay). The second delay in reaching health care is
closely linked to the contextual elements, and the third delay in
getting quality care is related to the barriers at the health
system.Several barriers thatwe identiﬁedwere comparable to
ﬁndings in a community-based study in the same area28: lack
of money for treatment and transport, distance, impassability
of roads, work priorities, and gender inequality. A more recent
study in 201223 reported that the population around Tabarak
Allah (where MSF runs a kala-azar center since 2009) have
adequate access to care, but our ﬁndings show that this is not
necessarily the case elsewhere. Geographical and ﬁnancial
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barriers are essential,11,45–47 and the situation is more com-
plicated than assuming that increasing the number of hospi-
tals would be the solution.48
In this study, participants were well aware of kala-azar as an
important communicable disease, as have been reported in
other kala-azar endemic settings.49–51 Thecardinal symptoms
are known, althoughmisconceptions of the disease regarding
its real cause and transmission remain. The knowledge on
sandﬂy, its habitats in certain trees or cracks were translated
to prevention efforts: vector-speciﬁc (bed nets, spraying,
cutting trees, repellant oil, etc.) or general ones such as im-
proving hygiene. As kala-azar seems to persist in the com-
munity; there is a sense of eroded trust in the preventive
measures promoted by health providers. The perceived se-
verity of kala-azar is the main drive behind the continuation of
suchpractices, despite the lack of evidence of effective vector
control in this area.15,52,53
We did not ﬁnd local explanatory models of disease54 that
are incongruent with the biomedical knowledge that has
spread along with efforts to control the disease. None of the
participants explained kala-azar as related to the supernatu-
ral, magical or religious factors, indicating that the prevailing
belief is of naturalistic causality.55 When asked about the use
of traditional medicine, people unanimously said that these
things are not for kala-azar. However, people also described
these traditional practices for several kala-azar–associated
symptoms, such as the swollen spleen (tohaal) with burning or
jaundice with herbal remedies. Therefore, despite a relatively
high level of knowledge about the disease, this may not nec-
essarily mean that there is no “shopping around” for treat-
ment. The study by Gerstl et al.28 described similar behavior,
although they found that disease awareness was low. The
care-seeking itineraries for kala-azar are not straightforward;
they appear to depend on the symptoms, perceived cause,
duration, severity, and role of the person in the households.
Diagnosing kala-azar is seen as a critical difﬁculty for the
people, as the gateway to treatment is only through a positive
diagnostic test. Kala-azar is perceived as a disease that is in
hiding. Thus various examinations are required, and other
diseases must be treated ﬁrst—most notably malaria and ty-
phoid. There seems to be a low awareness on the type of the
tests that is adequate to diagnose kala-azar. Gadarif is an un-
stable seasonal malaria area, and concomitant malaria among
kala-azarpatients isestimated to rangebetween4%and61%.56
Hence, theperceptionofmalaria evolving tokala-azarmayorigin
from the standard clinical practice of ruling out malaria ﬁrst.
The attitude of “doing everything” to get a positive kala-azar
test further fuels the frequent belief that certain food would
help to diagnose kala-azar. Although perhaps based on ob-
servations and experience, the belief reﬂects the hot–cold
dichotomy in a healthy equilibrium state, a symbolic notion
found in many cultures.55,57 People reported that the reason
FIGURE 2. Summary of access barriers to kala-azar care in southern Gadarif, Sudan. This ﬁgure appears in color at www.ajtmh.org.
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behind giving banana and chicken to a kala-azar–suspected
patient is to amplify the hot power that is raging in the patient’s
body—the heightened heat would surely make the diagnosis
positive. It seemsunusual tocongratulatesomeoneofbeingsick
(with kala-azar), yet in this context, it symbolizes the end of an
arduous journey and hopes that the cure is ﬁnally within reach.
Our study found a positive perception toward allopathic
treatment: people are convinced that kala-azar needs to be
ultimately treated by (medical) injection at the hospitals. Al-
though acknowledged as “hard”medicine because of the side
effects, they trust that the drug is making the patients well
again, an essential factor for compliance.58 Negative percep-
tions prevail toward the quality of care that is provided at the
public hospitals, primarily related to the limited resources such
as theavailability of thedoctorsandmore importantly, thedrug.
In Rahad andGalabat localities, the recurrent stock-outs of the
medicine were criticized as they can lead to interruption of
treatment. Illicit trade in medicines adds to the dissatisfaction
with the service, especially when they compare with centers/
hospitals receiving external support from NGOs. This has led
people to take the journey to these centers, or to Gadarif city,
thus not necessarily utilizing the closest health facility.
An overarching barrier for accessing kala-azar care is the
cost of an episode—being sick with kala-azar implies paying
for multiple tests, treatments, and hospitalization. Financial
constraints were given as the most plausible explanation for
why kala-azar patients wait for weeks and months before
going to the hospitals. The fact that the medicine is for free
(and not the diagnostic tests) does not compensate for the
considerable costs that the family has to spend from the
pocket directly, and although we did not ﬁnd evidence that
treatment compliance is jeopardized, several coping mecha-
nisms (such as borrowing or selling assets) were clearly in
place. Financial barriers during the rainy season—due to in-
creased transport cost related to the physical barriers—are
particularly cumbersome for those without a stable income.
Our ﬁndings are consistent with an earlier economic analysis
of kala-azar in Sudan, which estimated the total cost at US
$450 for an episode,11 totally unaffordable for most sub-
sistence farmers in this area (61% of the population are re-
ported to live below the poverty line of 250SDG [US$37] per
month59). Although women need their husband’s permission
to seek care in this culture,28 the delay is often due to lack of
money. People also more readily travel to free-of-charge
treatment centers or the ones known to offer more in-kind
support (nutrition, etc.). However, the rigidly deﬁned gender
roles for women and their unequal access to resources com-
pound more difﬁculties for women.
Theparticipants indicated that somebarriers havebeen and
could be ameliorated through several interventions. Health
education to address themisconceptions and to empower the
community in negotiating access in the medical system is
demanded. Although active case detection was deemed un-
necessary in areas with good access to treatment centers,23 a
more targeted approach toward villages with least access to
services after the rainy/autumn season should help save lives.
The poorest and those who live furthest away could beneﬁt
from a targeted support system, such as transport loan funds,
health insurance, community loan funds, or charity such as the
Islamic “zakat.” Quality of care should be standardized,
through equitable distribution of resources to the hospitals.
Health system strengthening efforts will beneﬁt kala-azar
patients through improvement of the supply systemandoffset
the discrepancies between NGO–supported centers and
public ones. Another recommendation that goes beyond the
health sector is to enhance thepropoor policies inGadarif, and
government to step up its actions in reducing poverty. The
sustainability of access-to-care for kala-azar needs political
and resources commitments.
One limitation of our study was that we did not fully capture
the perspective of children and adolescents, who make up
most kala-azar patients in Sudan. The groupdiscussionswere
conducted in gender division, but the varied age in each group
may limit the younger participants in expressing their views.
We also could not explore fully the ethnic dimensions in the
study as it was not possible to conduct the data collection and
enroll participants along tribal lines in the current political cli-
mate in Sudan. We cannot exclude the social desirability bias
in some of the responses, knowing the ﬁeld team came from
Gadarif. Although generalizability is chided as a limitation in a
qualitative study,57 we believed that reasonable extrapolation
of our ﬁndings is not impossible. The generalizability of this
study does not derive mechanistically from the sample but
from the concepts emerging from the ﬁndings (such as the
delay in diagnosis or persistent economic burden) that may
well be relevant to other settings or other health problems. The
context of Gadarif is speciﬁc, yet the suffering is not.
We believe this study offers a timely thorough insight into
the community perspective on kala-azar in this area and help
explain the reasons behind the delay in seeking kala-azar care
documented in quantitative surveys.60,61 It is essential for
policymakers and other stakeholders to understand the bar-
riers explored here as reducing delay would be contingent on
addressing these. In regard to the technical tools, there has
beenprogress in the recent decade, i.e., theRDT and a shorter
treatment regimen, yet these are still far from optimal. Several
factors revealed here merit further research, such as the di-
agnostic bottlenecks (lack of trust in RDT, an algorithm for
prolonged fever such as kala-azar) andmore empirical studies
to measure the various dimensions of access over time that
may predict health behavior, service utilization, and health
outcomes. Last but not least, development of better vector
control tools and other preventive measures is critical to
lessen the kala-azar burden to thecommunities in the long run.
CONCLUSION
Kala-azar is an infectious disease of poverty in southern
Gadarif, Sudan. Despite allegedly more efforts to control the
disease, the access to quality kala-azar care remains
problematic as is observed for many other health conditions
in such settings.62 To alleviate suffering, the multiple barriers
they face should be considered before implementing any in-
terventions. The ﬁnancial accessibility should be prioritized
through a multisectoral approach designed to have wider
beneﬁt for health for all.
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